glycogen synthase

glycogen synthase
Name	Glycogen synthase
Organism	Homo sapiens
Taxid	9606
Uniprot	P13822 / P35573
Length	704–717 aa
Localization	Cytosol; Liver; Skeletal muscle

glycogen synthase

Glycogen synthase is a key enzyme in Glycogen biosynthesis that catalyzes the elongation of α-1,4-glycosidic bonds using UDP-glucose as donor; it exists in isoforms with distinct tissue expression and regulation. First characterized by biochemical studies in the early 20th century, glycogen synthase has been the subject of investigations by research groups at institutions such as Massachusetts Institute of Technology, Harvard University, and the Max Planck Society for its central role in Metabolism and metabolic diseases. Mutations and dysregulation of glycogen synthase are implicated in hereditary disorders described by clinicians at centers like Mayo Clinic and research consortia including the Human Genome Project.

Structure and Isoforms

Mammalian glycogen synthase occurs primarily as two genetically distinct isoforms, encoded by GYS1 (muscle) and GYS2 (liver), with protein lengths ~708–717 amino acids determined by sequence analyses at European Molecular Biology Laboratory and National Institutes of Health sequencing centers. High-resolution structures from groups at European Synchrotron Radiation Facility and cryo-EM labs at Max Planck Institute reveal a multi-domain architecture forming a homotetrameric assembly that accommodates UDP-glucose in a conserved glycosyltransferase family GT-B fold, comparable to structures reported for enzymes solved at Rutherford Appleton Laboratory and Argonne National Laboratory. The catalytic core contains Rossmann-like nucleotide-binding motifs first characterized by researchers at University of Cambridge and Imperial College London, while C-terminal regulatory tails include multiple serine-rich clusters targeted by kinases identified in studies at Stanford University and University of California, San Francisco.

Function and Catalytic Mechanism

Glycogen synthase transfers glucosyl units from UDP-glucose to the non-reducing ends of glycogen via an SN2-like mechanism, as proposed in mechanistic models developed by investigators at California Institute of Technology and University of Oxford. Kinetic analyses performed in laboratories at Johns Hopkins University and University of Wisconsin–Madison demonstrate Michaelis–Menten behavior with substrate affinities modulated by allosteric effectors such as glucose-6-phosphate, findings corroborated by isotope-tracing experiments from teams at Cold Spring Harbor Laboratory and Salk Institute. Mutagenesis studies carried out by groups at University of Tokyo and University of Toronto identified active-site residues that coordinate UDP and the glucosyl acceptor; computational chemistry simulations from researchers at ETH Zurich and Princeton University support transition-state stabilization via hydrogen-bond networks akin to other glycosyltransferases.

Regulation and Post-translational Modifications

Glycogen synthase activity is tightly regulated through reversible phosphorylation and allosteric activation. Protein kinases such as glycogen synthase kinase-3 (GSK-3) and protein kinase A (PKA), characterized in seminal work at University of Dundee and Yale University, phosphorylate serine/threonine clusters to reduce activity, while protein phosphatase 1 (PP1) complexes, identified by teams at Duke University and University of Pennsylvania, dephosphorylate glycogen synthase to restore activity. Insulin signaling via the Insulin receptor and downstream effectors including Phosphoinositide 3-kinase and Akt (protein kinase B) modulates phosphorylation state, a regulatory axis elucidated by research at University of California, Berkeley and Columbia University. Additional post-translational modifications such as O-GlcNAcylation and acetylation have been reported in proteomic surveys from European Bioinformatics Institute and Broad Institute, influencing enzyme stability and interaction with glycogen-targeting subunits discovered at KU Leuven.

Tissue Distribution and Physiological Roles

GYS1 (muscle isoform) predominates in Skeletal muscle and heart, supporting exercise-related glycogen mobilization studied by sports physiologists at Loughborough University and cardiology groups at Cleveland Clinic. GYS2 (liver isoform) is primarily expressed in Liver hepatocytes, regulating postprandial glucose homeostasis in pathways investigated at Imperial College London and metabolic centers like Joslin Diabetes Center. Beyond energy storage, glycogen synthase contributes to glycogen-dependent signaling platforms implicated in neuronal function explored at University College London and in fetal development researched at University of Edinburgh. Comparative studies across species at University of Cambridge zoology departments show conserved roles in Drosophila and Caenorhabditis elegans glycogen metabolism.

Clinical Significance and Diseases

Mutations in GYS2 cause glycogen storage disease type 0, a hepatically centered disorder described in case series from Great Ormond Street Hospital and metabolic clinics at Children's Hospital of Philadelphia. Altered GYS1 function is linked to cardiomyopathies and exercise intolerance reported by investigators at Mount Sinai Hospital and genetic consortia including ClinVar contributors. Dysregulated glycogen synthase activity contributes to pathological glycogen accumulation in disorders such as Lafora disease and certain cancers, pathologies investigated by teams at University of Basel and oncology groups at MD Anderson Cancer Center. Therapeutic strategies targeting upstream regulators like GSK-3 and Akt have been pursued in clinical trials coordinated by pharmaceutical partners and academic centers including National Cancer Institute and GlaxoSmithKline.

Experimental Methods and Assays

Biochemical assays for glycogen synthase activity employ incorporation of radiolabeled UDP-[14C]-glucose in protocols developed in laboratories at Rosalind Franklin Institute and enzymology groups in the Pasteur Institute, with modern colorimetric and HPLC-based assays refined at Scripps Research. Structural studies utilize X-ray crystallography and cryo-EM at facilities such as Diamond Light Source and EMBL; site-directed mutagenesis and mass spectrometry mapping of phosphorylation sites are standard in molecular biology cores at Wellcome Trust and Proteome Center Magdeburg. In vivo models include Gys1 and Gys2 knockout mice generated and phenotyped at institutions like Jackson Laboratory and transgenic models studied at NIH animal facilities, while clinical assays for glycogen storage disorders are performed in diagnostic labs at Laboratory Corporation of America.

Category:Enzymes